The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


DPH DECHRA PHARMACEUTICALS PLC ORD 1P

DECHRA PHARM  Currency  GBX  Premium Equity Commercial Companies


Income Statement  (£ m) 30-Jun-14 30-Jun-13 30-Jun-12 30-Jun-11 30-Jun-10
Continuing Operations
Revenue  193.57 189.18 124.33 389.24 369.37
Operating Profit/(Loss)  25.00 18.34 10.27 21.72 19.87
Net Interest  0.05 0.00 2.87 3.90 3.37
Profit Before Tax  21.44 12.48 6.11 18.51 17.73
Profit After Tax  19.42 10.85 3.91 14.13 13.16
Discontinued Operations
Profit After Tax  0.92 8.53 7.84 0.00 0.00
PROFIT FOR THE PERIOD  20.34 19.38 11.75 14.13 13.16
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  20.34 19.38 11.75 14.13 13.16
 
Continuing EPS
Earnings per Share - Basic  22.22p 12.47p 5.20p 21.33p 19.97p
Earnings per Share - Diluted  22.14p 12.39p 5.18p 21.26p 19.89p
Earnings per Share - Adjusted  36.45p 29.27p 21.35p 34.33p 29.50p
Continuing and Discontinued EPS
Earnings per Share - Basic  67.57p 20.59p 15.65p 21.33p 19.97p
Earnings per Share - Diluted  67.33p 20.45p 15.60p 21.26p 19.89p
Earnings per Share - Adjusted  37.61p 38.98p 32.37p 34.33p 29.50p
 
Dividend per Share  14.41p 12.84p 12.50p 10.90p 9.40p

Balance Sheet  (£ m) 30-Jun-14 30-Jun-13 30-Jun-12 30-Jun-11 30-Jun-10
Assets
Non-Current Assets
Property, Plant & Equipment  18.26 16.07 16.72 7.72 7.67
Intangible Assets  196.18 219.60 225.87 125.10 80.37
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  214.44 235.67 242.59 132.82 88.04
Current Assets
Inventories  29.67 29.20 57.28 40.76 34.82
Trade & Other Receivables  29.89 27.68 72.11 66.29 51.16
Cash at Bank & in Hand  26.77 32.79 32.44 30.50 31.50
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 89.78 0.00 0.00 0.00
  86.33 179.46 161.83 137.55 117.48
 
Total Assets  300.77 415.13 404.42 270.37 205.53
 
Liabilities
Current Liabilities
Borrowings  -0.10 -9.75 -5.11 -8.50 -20.44
Other Current Liabilities  -35.61 -93.77 -98.36 -80.45 -68.60
  -35.72 -103.52 -103.46 -88.95 -89.04
 
Net Current Assets  50.62 75.94 58.37 48.60 28.44
 
Non-Current Liabilities
Borrowings  -31.66 -103.84 -114.05 -56.09 -17.76
Provisions  -21.50 -27.18 -29.34 -13.44 -12.50
Other Non-Current Liabilities  -7.10 -5.97 -3.89 -13.56 0.00
  -60.25 -136.99 -147.28 -83.08 -30.26
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -95.97 -240.51 -250.74 -172.04 -119.30
 
Net Assets  204.81 174.62 153.68 98.33 86.23
 
Capital & Reserves
Share Capital  0.88 0.87 0.87 0.66 0.66
Share Premium Account  124.43 123.49 122.64 63.56 63.02
Other Reserves  -7.99 10.88 -2.20 6.23 2.83
Retained Earnings  87.49 39.38 32.37 27.88 19.71
Shareholders Funds  204.81 174.62 153.68 98.33 86.23
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  204.81 174.62 153.68 98.33 86.23

Ratios - based on IFRS 30-Jun-14 30-Jun-13 30-Jun-12 30-Jun-11 30-Jun-10
Continuing Operations
PE Ratio - Adjusted  19.85 23.57 22.76 14.30 13.05
PEG - Adjusted  0.81 0.64 -0.60 0.87 0.86
Earnings per Share Growth - Adjusted  24.53% 37.10% -37.81% 16.37% 15.19%
Dividend Cover  2.53 2.28 1.71 3.15 3.14
Revenue Per Share  221.51p 217.42p 165.59p 587.50p 560.53p
Pre-Tax Profit per Share  24.54p 14.34p 8.14p 27.94p 26.91p
Operating Margin  11.03% 6.56% 7.17% 5.46% 5.44%
Return on Capital Employed  34.14% 12.89% 11.72% 43.72% 37.30%
 
Continuing & Discontinued Operations
Dividend Yield  1.99% 1.86% 2.57% 2.22% 2.44%
Dividend per Share Growth  12.23% 2.72% 14.68% 15.96% 10.59%
Net Asset Value per Share (exc. Intangibles)  9.83p -51.61p -83.10p -40.28p 8.86p
Net Gearing  2.44% 46.27% 56.43% 34.67% 7.77%

Data is provided by Morningstar


DECHRA PHARM share - fundamentals

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds